{
    "nct_id": "NCT06319963",
    "official_title": "An Open-Label Phase 1/2a Clinical Trial to Evaluate the Safety, Immunogenicity, and Preliminary Efficacy of a Lentiviral Vector-Based Therapeutic Vaccine Against Human Papilloma Virus (Lenti-HPV-07) in Participants with HPV-Associated Oropharyngeal Squamous Cell Cancer or Cervical Cancer",
    "inclusion_criteria": "* histologically confirmed invasive HPV-related oropharyngeal or cervical cancer\n* ECOG performance status of 0 or 1\n* adequate hepatic, renal, pulmonary, and bone marrow/hematological function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "- with seropositivity for HIV, active hepatitis C virus (HCV) infection, or hepatitis B (HBV) infection",
    "miscellaneous_criteria": ""
}